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ABSTRACT: Machine learning algorithm plays an important role in our life. It is the subset 
of Artificial intelligence. Recently, everyone tries to use AI or try to invent something 
related to    AI for making life easier. In the medical field, Machine learning is used for the 
recognition and classification of diseases. It can classify cancer, diabetes or other diseases 
more accurately from datasets. So, we propose a model which is the combination of 
Support vector machine and Ad boost. This combine method is known as Ensemble learner. 
In this paper, we are predicting diabetes and breast cancer. We have used SVM for 
classification purpose then have applied Ad boost for boosting purposes. The number of a 
diabetes patient is increasing very rapidly. It causes many other diseases like kidney failure; 
Eye disorder etc. No medicines are invented to prevent diabetes fully.  Breast cancer is 
increasing very rapidly between women. The cost of breast cancer treatment is very high. 
More researches are running on diabetes and breast cancer. We proposed our model to 
predict the diseases more accurately rather than the previous models. 
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1. Introduction 
 Health is wealth. The development of a country 
mostly depends on the health condition of the people. So we 
proposed a model to predict the diseases. In this purpose, we 
used machine learning approaches and predicted that a 
person is suffering from diabetes and breast cancer. Machine 
learning is a method to predict any new information based 
on previous information. It helps us to classify, cluster or 
boost data. In this paper, we basically used the classification 
and the boosting method. For classification purposes, we 
used a support vector machine. We used Adaboost for 
boosting performance. A Support Vector Machine (SVM) is a 
discriminative classifier formally defined by a separating 
hyper plane. In other words, given labeled training data, the 
algorithm outputs an optimal hyper plane which categorizes 
new examples. In two dimensional spaces, this hyper plane is 
a line dividing a plane into two parts wherein each class lay 
on either side [1]. Adaboost classifier combines the weak 
classifier algorithm to form a strong classifier. A single 
algorithm may classify the objects poorly but if we combine 
multiple classifiers with the selection of training set during 
each iteration and assigning the right amount of weight in 
the final voting, we can have a better accuracy score for the 
overall classifier [2]. 
 
 
Fig1. The Block Diagram of Our Proposed Model perceptron algorithm. 
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 Diabetes is a disease in which your blood glucose, or 
blood sugar, levels are too high. Glucose comes from the 
foods take you to eat. Insulin is a hormone that helps the 
glucose to      get into your cells to give them energy. With 
type 1 diabetes, your body does not make insulin. With type 
2 diabetes, which is the common type, your body does not 
make or use insulin well. Diabetes can damage your eyes, 
kidneys, and nerves [3]. Breast cancer can happen when cells 
in the breast begin to grow out of control. These cells usually 
form a tumor that can often be seen on an x-ray or can be 
felt as a lump. The tumor is malignant (cancer) if the cells 
can grow into (invade) surrounding tissues or spread 
(metastasize) to distant areas of the body. Breast cancer 
occurs almost entirely in women, but man can also be 
affected by breast cancer, too [4]. By using our model based 
on certain data, we can predict that a person is suffering 
from diabetes and cancer or not. If we predict this accurately 
than the person will take treatment timely. As a result, they 
can improve from diseases as early as possible. 
 In this paper, Section II contains the related work 
which is proposed by many author’s, Section III describes the 
Machine Learning Algorithms at orange software which is 
used in our model, Section IV is a methodology where we 
describes our proposed model, Section V is an experimental 
evolution where we describe the description of our data, 
Section VI is a result analysis step where we describe the 
result of our model, Section VII we concluded our work. 
2. Related Work 
 C. Kalaiselvi and Dr. G. et al., [5] proposed an 
Adaptive Neuro-Fuzzy Inference System (ANFIS) to diagnose 
diabetes. The number of times Pregnant, Plasma Glucose 
level, diastolic blood pressure(mm Hg), skin rashes and 
thickness(mm), 2 Hrs Serum Insulin, BMI, diabetes pedigree, 
age parameters are taken to diagnose diabetes [6]. Proposed 
K-means, which is also used for data reduction with the J48 
decision tree as a classifier for classification.  In order to get 
the experimental result, they used the Pima Indians Diabetes 
Dataset from the UCI Machine Learning Repository. Dr. Prof. 
Neeraj, using J48 data mining algorithm to diagnose the 
breast cancer [7]. Analyzing the decision tree generated by 
the algorithm using 10-fold cross-validation method to 
predict the recurrent events, based on the attributes such as 
node-caps, a degree of malignancy, age, tumor-size, 
menopause, irradiate they combine the five algorithms such 
as Nave Bayes, SMO, REP Tree, J48 and MLP algorithms, a 
classify breast cancer and diabetes. After analysing the 
performances of all algorithm, found that nave Bayes gives 
72.70 percent accuracy on breast cancer dataset and SMO 
gives 76.80 percent accuracy on diabetes dataset [8]. To 
diagnose diabetes proposed a learning algorithm which 
ensemble boosting algorithm with the perceptron algorithm 
to improve the performance of the perceptron algorithm in 
the prediction of undiagnosed patients [9]. The proposed 
method is tested on three different publicly available datasets 
and compared with the performance of the perceptron 
algorithm. 
3. Machine Learning Algorithms at Orange Software 
A. Support Vector Machine 
 SVM is a machine learning technique that separates 
the attributes space with a hyperplane, thus maximizing the 
margin between the instances of different classes or class 
values. The technique often yields supreme predictive 
performance results. Orange embeds a popular 
implementation of SVM of the LIBSVM package. This widget 
is its graphical user interface. Its estimation accuracy 
depends on a good setting on cost (C), regression loss 
epsilon(s) and kernel parameters. In orange, we found two 
types of SVM based on different maximization of the error 
function. The Kernel is a function that transforms attribute 
space into a new feature space to fit the maximum- margin 
hyperplane. There are also three parameters based on a 
model. The parameter is g, c, and d. g is the gamma constant 
in kernel function which recommended value is 1/k where k 
is the number of the attributes. c for the constant co in the 
kernel function which default value is zero and d for the 
degree of the kernel which default value is three [10]. 
B. Adaboost 
 The Adobos (short for “Adaptive boosting”) widget 
is a machine-learning algorithm, formulated by “Yoav 
Freund and Robert Schapire”. It can be used with other 
learning algorithms to boost their performance. It does so by 
tweaking the weak learners. Adaboost works for both 
classification and regression. In orange, Adaboost contains 
three parameters. The first parameter is the number of 
estimators, the second parameter is learning rate, which 
determines to what extent the newly acquired information 
will override the old information (0 = the agent will not 
learn anything, 1 = the agent considers only the most recent 
information), the third parameter is fixed seed for random 
generator which is used to reproduce the result by setting a 
fixed seed. In orange ad boost contains two types of boosting 
method which is a classification algorithm and regression 
loss function [11]. 
4. Methodology 
 For the purpose of prediction, a prediction model 
was defined. The working principle of the proposed model 
has been shown in Fig.1.In our model; we had taken 75 
percent data for training purpose and remaining 25 percent 
data put for testing purpose. 
 
Fig2. The Classification of Cancer Dataset 
 To get a better result, we need to set    the cost, the 
regression loss epsilon, and the kernel function. In our 
model, we used the sigmoid kernel function, set the cost of 
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the higher value and the regression loss epsilon lower value. 
But the overall performance is very poor. So, according to 
Fig.1, we sent all the classification result in the boosting step. 
We were needed to apply to boost purpose, we used the 
Adaboost algorithm. In this case, we also needed to set two 
parameters. The first one is the number of estimators and the 
second one is the learning rate. We use test data to predict    
the result. The predictor function gives the predicted report. 
At last, we had the main part of our model is ensemble 
learning. The method of combining classification and 
boosting algorithms together is known as the ensemble 
learning. In the ensemble learning, we have two parts. The 
first part is the classification and the second part is boosting. 
Before classifying, we had divided the training data into a 
three sampler part. Then we applied the SVM classification 
algorithm. This classification algorithm classified the 
training data properly which we see in the Fig.2 and Fig.3. In 
Fig.2, we classify the cancer dataset where “1” that means 
blue circle indicates the healthy people and “2” that means 
red circle indicates the cancer patient. In Fig.3, we classify 
the diabetes dataset where “0” that means blue circle 
indicates the healthy people and “1” that means red circle 
indicates the Diabetes patient measured the overall 
performance. 
Fig 3. The Classification of Diabetes Dataset 
5. Experimental Evaluation 
A. Diabetes Dataset 
 The Pima Indian Diabetes dataset is used for 
Training and testing our model. We use the database because 
it is available free of charge for use in non-commercial 
research. This data- set contains 768 Number of Instances. 
Attribute information  
• Number of times Pregnant 
• Plasma Glucose level 
• Diastolic Blood pressure (mm/Hg) 
• Skin rashes and thickness (mm) 
• 2Hrs Serum Insulin 
• BMI 
• Diabetes pedigree 
• Age 
All the input parameters have numeric values. The 
First parameter is the total number of times the patient 
Pregnant. The second parameter is plasma glucose 
Concentration 2 hours in an oral. The third parameter is the 
diastolic blood pressure value which is measured in mm by 
Hg. The fourth parameter is skin rashes and thickness, which 
is measured in mm. The fifth parameter is 2-hours serum 
insulin test which finds the amount of Insulin creation in the 
patient’s body. The sixth parameter is the patient’s body mass 
index. The seventh parameter is the Diabetes pedigree which 
is the function value based on the diabetes family Hierarchy. 
The last parameter is age. The output parameter is classified 
into two categories. Class value- 0 is interpreted as tested 
negative for Diabetes; Class Value-1 is interpreted as tested 
positive for Diabetes [12]. 
B. Cancer Dataset 
 The Coimbra breast cancer dataset is used for 
training and testing our model. We use the database because 
it is available free of charge for use in non-commercial 
research. This dataset contains 116 numbers of instances. 
Attribute information 
• Age (years) 
• BMI (kg/m2) 
• Glucose (mg/dL) 
• Insulin (U/mL) 
• HOMA 
• Leptin (ng/mL) 
• Adiponectin (g/mL) 
• Resistin (ng/mL) 
• MCP-1(pg/dL) 
 All the input parameters have numeric values. The 
First parameter four parameter descriptions is the same as 
the previous data-set. The fifth parameter is HOMA which is 
a method for assessing -cell function and insulin resistance 
(IR) from basal (fasting) glucose and insulin or C-peptide 
concentrations. The sixth parameter Leptin is is measured in 
ng by mL.   The seventh parameter Adiponectin that is 
measured in g by mL.The eighth parameter Resistin which is 
measured in ng  by mL.The last parameter MCP-1 Which is 
measured in pg  by dL. The output parameter is classified 
into two categories. Class value-1 is interpreted as no cancer 
and class value-2 is interpreted as cancer patient [13]. 
6. Result Analysis 
 The first step of our model is a classification. After 
classifying, we are measuring the performance. For 
measuring performance, we use five parameters.The 
parameters are Area under ROC is the area under the 
receiver-operating curve,  
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Fig4. Performance Analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7. Conclusion 
 To predict diabetes and cancer many pieces of 
research are going. This paper discusses about a new 
approach for the prediction of diabetes and breast cancer 
using medical records of the patient. We use data-set for 
training and testing purpose. SVM is used to classify the 
data-set. For increasing the overall performance we apply 
boosting method after classification. This combined method 
gives more accuracy, precision, recall, and F-measure. From 
the classification and boosting rule, we take a decision that 
who is diabetes positive or negative and who is breast cancer 
positive or negative. So the method can be used by medical 
field to predict these diseases. In the future, we try to predict 
other diseases like lung cancer, brain tumor etc using this 
method. For the benefit of the medical field, we can use this 
model present and future as well. 
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